1. Bayoumi, Ali, Jalil, Ismail, Metwally, Mayada, George, Jacob, Eslam, Mohammed. 2020. Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease. In PloS one, 15, e0243590. doi:10.1371/journal.pone.0243590. https://pubmed.ncbi.nlm.nih.gov/33306709/
2. Sieroń, Aleksander L, Stańczak, Paweł. 2005. ASD--lessons on genetic background from transgenic mice with inactive gene encoding metalloprotease, Tolloid-like 1 (TLL1). In Medical science monitor : international medical journal of experimental and clinical research, 12, RA17-22. doi:. https://pubmed.ncbi.nlm.nih.gov/16369476/
3. Enomoto, Hirayuki, Aizawa, Nobuhiro, Hasegawa, Kunihiro, Iijima, Hiroko, Nishiguchi, Shuhei. 2020. Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients. In International journal of molecular sciences, 21, . doi:10.3390/ijms21093089. https://pubmed.ncbi.nlm.nih.gov/32349377/
4. Zain, Maryam, Awan, Fazli Rabbi, Cooper, Jackie A, Ireland, Helen, Humphries, Steve E. . Association of TLL1 gene polymorphism (rs1503298, T > C) with coronary heart disease in PREDICT, UDACS and ED cohorts. In Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 24, 615-9. doi:. https://pubmed.ncbi.nlm.nih.gov/25233961/
5. Clark, T G, Conway, S J, Scott, I C, Hogan, B L, Greenspan, D S. . The mammalian Tolloid-like 1 gene, Tll1, is necessary for normal septation and positioning of the heart. In Development (Cambridge, England), 126, 2631-42. doi:. https://pubmed.ncbi.nlm.nih.gov/10331975/
6. Yamada, Mamiko, Suzuki, Hisato, Miya, Fuyuki, Takenouchi, Toshiki, Kosaki, Kenjiro. 2022. Deciphering complex rearrangements at the breakpoint of an apparently balanced reciprocal translocation t(4:18)(q31;q11.2)dn and at a cryptic deletion: Further evidence of TLL1 as a causative gene for atrial septal defect. In American journal of medical genetics. Part A, 188, 2472-2478. doi:10.1002/ajmg.a.62777. https://pubmed.ncbi.nlm.nih.gov/35567499/
7. Kamal, Ahmed, Mohsin, Ali Kareem, Matta, Cecil, Domiaty, Donia, Mohamed, Nema. 2022. Tolloid-like 1 gene variant rs17047200, pretreatment FIB-4, ALBI and PALBI scores as predictors of hepatocellular carcinoma occurrence after directly acting antivirals. In Clinical and experimental hepatology, 8, 330-334. doi:10.5114/ceh.2022.122289. https://pubmed.ncbi.nlm.nih.gov/36683867/
8. Degasperi, Elisabetta, Galmozzi, Enrico, Facchetti, Floriana, Iavarone, Massimo, Lampertico, Pietro. 2019. TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antivirals. In Journal of viral hepatitis, 26, 1233-1236. doi:10.1111/jvh.13155. https://pubmed.ncbi.nlm.nih.gov/31177595/
9. Kiso, Ayumi, Toba, Yukiko, Tsutsumi, Susumu, Takayama, Kazuo, Mizuguchi, Hiroyuki. 2020. Tolloid-Like 1 Negatively Regulates Hepatic Differentiation of Human Induced Pluripotent Stem Cells Through Transforming Growth Factor Beta Signaling. In Hepatology communications, 4, 255-267. doi:10.1002/hep4.1466. https://pubmed.ncbi.nlm.nih.gov/32025609/